MetaADEDB 2.0 @ LMMD
BMS-790052
(FKRSSPOQAMALKA-CUPIEXAXSA-N)
Structure
SMILES
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc([nH]1)c1ccc(cc1)c1ccc(cc1)c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)OC)C(C)C
Type(s)
Approved; Investigational
ATC code(s)
J05AP07
Molecular Formula:
C40H50N8O6
Molecular Weight:
738.875
Log P:
6.8796
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
4
TPSA:
174.64
CAS Number(s):
1009119-64-5; 1009119-65-6; 1214735-16-6
Synonym(s)
1.
BMS-790052
2.
Daklinza
3.
daclatasvir
External Link(s)
MeSHC549273
PubChem Compound25154714
BindingDB50387084
ChEBI82977
CHEMBLCHEMBL2023898
DrugBankDB09102
DrugCentral4875
KEGGdr:D10065
dr:D10105
Therapeutic Target DatabaseD09SGV
ZINC68204830
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 149US FAERS
2HeadacheFAERS: 109US FAERS
3NauseaFAERS: 57US FAERS
4Drug dose omissionFAERS: 25US FAERS
5DizzinessFAERS: 16US FAERS
6Abdominal discomfortFAERS: 11US FAERS
7AstheniaFAERS: 10US FAERS
8MyalgiaFAERS: 10US FAERS
9PainFAERS: 10US FAERS
10PruritusFAERS: 10US FAERS
11Adverse eventFAERS: 9US FAERS
12ArthralgiaFAERS: 8US FAERS
13Back PainFAERS: 8US FAERS
14SomnolenceFAERS: 7US FAERS
15VomitingFAERS: 7US FAERS
16AlopeciaFAERS: 6US FAERS
17AnxietyFAERS: 6US FAERS
18Drug ineffectiveFAERS: 5US FAERS
19Dry skinFAERS: 5US FAERS
20MalaiseFAERS: 5US FAERS
21Weight decreasedFAERS: 5US FAERS
22ConstipationFAERS: 4US FAERS
23DyspepsiaFAERS: 4US FAERS
24Feeling abnormalFAERS: 4US FAERS
25Incorrect product storageFAERS: 4US FAERS
26Memory impairmentFAERS: 4US FAERS
27NasopharyngitisFAERS: 4US FAERS
28AmnesiaFAERS: 3US FAERS
29DysphoniaFAERS: 3US FAERS
30EpistaxisFAERS: 3US FAERS
31FlatulenceFAERS: 3US FAERS
32LethargyFAERS: 3US FAERS
33Peripheral swellingFAERS: 3US FAERS
34Product use issueFAERS: 3US FAERS
35TremorFAERS: 3US FAERS
36Wrong technique in product usage processFAERS: 3US FAERS
37jaundiceFAERS: 3US FAERS
38Abdominal PainFAERS: 2US FAERS
39AscitesFAERS: 2US FAERS
40Bone painFAERS: 2US FAERS
41Chest discomfortFAERS: 2US FAERS
42ChillsFAERS: 2US FAERS
43Depressed moodFAERS: 2US FAERS
44EosinophiliaFAERS: 2US FAERS
45General physical health deteriorationFAERS: 2US FAERS
46HypersensitivityFAERS: 2US FAERS
47InfluenzaFAERS: 2US FAERS
48Medication ErrorFAERS: 2US FAERS
49Mood swingsFAERS: 2US FAERS
50OverdoseFAERS: 2US FAERS
51SepsisFAERS: 2US FAERS
52Therapeutic response unexpectedFAERS: 2US FAERS
53Visual ImpairmentFAERS: 2US FAERS
54treatment failureFAERS: 2US FAERS
55Accidental overdoseFAERS: 1US FAERS
56Acute kidney injuryFAERS: 1US FAERS
57Ammonia increasedFAERS: 1US FAERS
58ArthritisFAERS: 1US FAERS
59Atrial FibrillationFAERS: 1US FAERS
60Blood glucose increasedFAERS: 1US FAERS
61BronchitisFAERS: 1US FAERS
62CataractFAERS: 1US FAERS
63Cerebrovascular accidentFAERS: 1US FAERS
64Chest PainFAERS: 1US FAERS
65CholestasisFAERS: 1US FAERS
66ChromaturiaFAERS: 1US FAERS
67ColitisFAERS: 1US FAERS
68CryingFAERS: 1US FAERS
69DehydrationFAERS: 1US FAERS
70Diabetes MellitusFAERS: 1US FAERS
71DiscomfortFAERS: 1US FAERS
72Disease recurrenceFAERS: 1US FAERS
73Drug DependenceFAERS: 1US FAERS
74Drug prescribing errorFAERS: 1US FAERS
75DysgraphiaFAERS: 1US FAERS
76DysuriaFAERS: 1US FAERS
77Emotional disorderFAERS: 1US FAERS
78Epigastric discomfortFAERS: 1US FAERS
79EructationFAERS: 1US FAERS
80ErythemaFAERS: 1US FAERS
81Eye irritationFAERS: 1US FAERS
82Febrile NeutropeniaFAERS: 1US FAERS
83Full blood count decreasedFAERS: 1US FAERS
84HepatomegalyFAERS: 1US FAERS
85HerniaFAERS: 1US FAERS
86HypersomniaFAERS: 1US FAERS
87Inappropriate schedule of drug administrationFAERS: 1US FAERS
88Incorrect dose administeredFAERS: 1US FAERS
89Initial insomniaFAERS: 1US FAERS
90Intestinal PerforationFAERS: 1US FAERS
91Lactose IntoleranceFAERS: 1US FAERS
92LeukoplakiaFAERS: 1US FAERS
93Maternal exposure during pregnancyFAERS: 1US FAERS
94Mental impairmentFAERS: 1US FAERS
95Musculoskeletal PainFAERS: 1US FAERS
96Nerve injuryFAERS: 1US FAERS
97Oropharyngeal painFAERS: 1US FAERS
98PancytopeniaFAERS: 1US FAERS
99Paranasal sinus discomfortFAERS: 1US FAERS
100PneumoniaFAERS: 1US FAERS
101Product dispensing errorFAERS: 1US FAERS
102Product packaging quantity issueFAERS: 1US FAERS
103Product quality issueFAERS: 1US FAERS
104Renal painFAERS: 1US FAERS
105Respiratory tract congestionFAERS: 1US FAERS
106RhabdomyolysisFAERS: 1US FAERS
107Rheumatoid ArthritisFAERS: 1US FAERS
108Septic ShockFAERS: 1US FAERS
109SinusitisFAERS: 1US FAERS
110StressFAERS: 1US FAERS
111Suicide attemptFAERS: 1US FAERS
112SwellingFAERS: 1US FAERS
113TachycardiaFAERS: 1US FAERS
114Throat irritationFAERS: 1US FAERS
115TinnitusFAERS: 1US FAERS
116ToothacheFAERS: 1US FAERS
117Urinary tract infectionFAERS: 1US FAERS
118UrticariaFAERS: 1US FAERS
119Vascular ruptureFAERS: 1US FAERS
120Vitamin D DeficiencyFAERS: 1US FAERS
121WheezingFAERS: 1US FAERS
122colonoscopyFAERS: 1US FAERS
123Hepatitis C, Chronic25987834CTD
124Hepatitis C25937625CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.